Tag: FDA generic drug surveillance
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
Dec 6 2025 / MedicationsThe FDA monitors generic drugs after approval using real-world data, adverse event reports, and inspections to catch safety issues that clinical trials miss. Learn how systems like FAERS and Sentinel protect patients every day.
VIEW MORE